Conmed (CNMD) Other Operating Expenses (2010 - 2026)

Conmed's Other Operating Expenses history runs 7 years deep, the most recent figure standing at $109.3 million for Q1 2026.

• Quarterly Other Operating Expenses fell 5.93% year-over-year to $109.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $344.7 million (up 83.82% YoY) and the FY2025 annual result came in at $460.0 million, changed N/A from the prior year.
• Other Operating Expenses was $109.3 million for Q1 2026 at Conmed, down from $132.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $132.4 million in Q4 2025 and bottomed at $71.3 million in Q3 2024.
• A 3-year average of $104.0 million and a median of $106.2 million in 2025 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2025 — Other Operating Expenses rose 26.96% — and 2026, when it fell 5.93%.
• Conmed's Other Operating Expenses stood at $71.3 million in 2024, then jumped by 85.62% to $132.4 million in 2025, then dropped by 17.45% to $109.3 million in 2026.
• Business Quant data shows CNMD's Other Operating Expenses at $109.3 million in Q1 2026, $132.4 million in Q4 2025, and $103.0 million in Q2 2025.